Today: 18 January 2026
Subscribe
Browse Category

Stock Market News 30 November 2025

Western Digital (WDC) Stock on November 30, 2025: Institutional Moves, AI Tailwinds and Holiday Storage Deals

Western Digital (WDC) Stock on November 30, 2025: Institutional Moves, AI Tailwinds and Holiday Storage Deals

Updated: November 30, 2025 Western Digital Corporation (NASDAQ: WDC) heads into December as one of 2025’s standout technology stocks. The shares closed on Friday, November 28, at $163.62, up about 3.7% on the day, near the upper end of their 52‑week range and several times higher than where they started the year. MarketBeat Driven by a ferocious boom in AI…
30 November 2025
···
Wells Fargo Stock News Today (WFC): Institutional Moves, Sector Rotation Call and AI Push – What Investors Need to Know on November 30, 2025

Wells Fargo Stock News Today (WFC): Institutional Moves, Sector Rotation Call and AI Push – What Investors Need to Know on November 30, 2025

Wells Fargo & Company (NYSE: WFC) heads into the final month of 2025 with its stock trading near the top of its 52‑week range, backed by strong earnings, aggressive capital returns and a fresh push into artificial intelligence. Today’s news flow is dominated by institutional investors reshuffling positions in WFC and a high‑profile call from Wells Fargo strategists for a…
30 November 2025
····
Applied Digital (APLD) Stock on November 30, 2025: AI Data Center Milestones, $2.35B Debt Deal and a 1GW Power Project

Applied Digital (APLD) Stock on November 30, 2025: AI Data Center Milestones, $2.35B Debt Deal and a 1GW Power Project

Applied Digital Corporation (NASDAQ: APLD) has packed an entire earnings season’s worth of headlines into a few weeks. As of the weekend of November 30, 2025, the stock sits around $27 per share, giving the company a market capitalization of roughly $7–8 billion after a year of explosive, volatility‑filled gains. Stocktwits At the same time, the company has: Here’s how…
30 November 2025
···
Intuit (INTU) Stock on November 30, 2025: Fresh FY 2026 Guidance, AI Megadeal and Big Fund Moves Explained

Intuit (INTU) Stock on November 30, 2025: Fresh FY 2026 Guidance, AI Megadeal and Big Fund Moves Explained

Published: November 30, 2025 Intuit Inc. (NASDAQ: INTU) is wrapping up November with a dense cluster of headlines: new fiscal 2026 earnings guidance, blockbuster AI partnerships, and notable shifts in positions held by major institutional investors. All of this comes just days after the company delivered strong first‑quarter results for its 2026 fiscal year. Here’s a deep dive into what…
30 November 2025
····
Cisco Systems Stock Today: AI Deals, Analyst Upgrades and Big-Money Moves – November 30, 2025 Update

Cisco Systems Stock Today: AI Deals, Analyst Upgrades and Big-Money Moves – November 30, 2025 Update

Cisco Systems (NASDAQ: CSCO) is ending November 2025 in a very different place than it started the year: trading near 52‑week highs, leaning hard into artificial intelligence infrastructure, and drawing fresh attention from Wall Street and big institutional investors. As of the close on November 28, Cisco Systems stock finished at $76.94, with an after‑hours quote of $77.10, near its…
30 November 2025
····
Adobe Stock (ADBE) on 30 November 2025: Price, Analyst ‘Hold’, AI Ambitions and Holiday E‑Commerce Tailwinds

Adobe Stock (ADBE) on 30 November 2025: Price, Analyst ‘Hold’, AI Ambitions and Holiday E‑Commerce Tailwinds

Adobe Inc. (NASDAQ: ADBE) heads into the final month of 2025 as one of the more controversial big-tech names on Wall Street. The stock is trading near the bottom of its 52‑week range, yet analyst price targets still imply substantial upside, and fresh data from Adobe’s own analytics business shows record online spending heading into the holidays. TradingView On 30…
30 November 2025
···
Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) – the company behind the da Vinci robotic surgery platform – is closing out November 2025 with a mix of powerful earnings, heavy institutional activity, and a stock price near record territory. As of the last close on November 28, 2025, Intuitive Surgical stock traded around $573.48 with a market capitalization of roughly $203.6 billion,…
30 November 2025
···
McDonald’s (MCD) Stock on November 30, 2025: Options Surge, Dividend Hike and Value Push Shape Investor Sentiment

McDonald’s (MCD) Stock on November 30, 2025: Options Surge, Dividend Hike and Value Push Shape Investor Sentiment

CHICAGO, November 30, 2025 — McDonald’s Corporation (NYSE: MCD) heads into the final month of 2025 with its share price hovering just above $311, sitting a few percentage points below record highs as investors digest strong value‑driven sales, a fresh dividend increase, and a spike in call‑option trading around the stock. Barchart On November 30, the latest coverage surrounding McDonald’s…
30 November 2025
····
Chevron (CVX) Stock on November 30, 2025: Record Output, 10% Cash‑Flow Target and a High‑Yield Test for Investors

Chevron (CVX) Stock on November 30, 2025: Record Output, 10% Cash‑Flow Target and a High‑Yield Test for Investors

Published: November 30, 2025 Chevron stock today: price, yield and performance snapshot Chevron Corporation (NYSE: CVX) heads into the final month of 2025 looking fundamentally strong but still fighting a perception problem in the market. As of the latest close on Friday, November 28, Chevron shares finished around $151.13, giving the company a market value of roughly $300–302 billion. Investing…
30 November 2025
····
Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield

Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield

Pfizer Inc. (NYSE: PFE) is back in the spotlight as of November 30, 2025. Fresh regulatory filings show new institutional buying, analysts are nudging price targets higher, and the company has closed a multibillion‑dollar obesity deal while reshaping its post‑pandemic pipeline. This article pulls together the most relevant current Pfizer stock news as of November 30, 2025, and explains what…
30 November 2025
····
Caterpillar (CAT) Stock News Today, November 30, 2025: Analyst Rating, Big Money Moves and Valuation Check

Caterpillar (CAT) Stock News Today, November 30, 2025: Analyst Rating, Big Money Moves and Valuation Check

Caterpillar Inc. (NYSE: CAT) heads into the final month of 2025 with its stock near record highs, fresh analyst endorsements, and another wave of institutional money shuffling positions in the industrial giant. On Sunday, November 30, 2025, new regulatory-filing coverage and analyst-tracking reports highlight three key developments for CAT investors: Taken together, today’s news does not change the fundamental story,…
30 November 2025
····
GE Vernova (GEV) Stock Near $600: Institutional Buying, Taiwan Wind Deal and AI Power Boom – November 30, 2025 Update

GE Vernova (GEV) Stock Near $600: Institutional Buying, Taiwan Wind Deal and AI Power Boom – November 30, 2025 Update

Published: November 30, 2025 GE Vernova Inc. (NYSE: GEV) heads into the final trading month of 2025 as one of Wall Street’s standout energy names. The stock is hovering just under $600 a share after a powerful multi‑month rally, bolstered by fresh institutional buying, a milestone wind-repowering deal in Taiwan, and a growing role in powering energy‑hungry AI data centers…
30 November 2025
····
1 … 1,070 1,071 1,072 1,073 1,074 … 1,439

Stock Market Today

  • Telix TLX valuation after first U.S. BiPASS Phase 3 patient dosed
    January 17, 2026, 7:02 PM EST. Telix Pharmaceuticals trades at A$11.48 after dosing the first U.S. patient in BiPASS Phase 3, spotlighting Illuccix and Gozellix in prostate cancer imaging. The update comes as the stock shows a 1-day gain of 2.96% and a 7-day gain of 2.14%. The rally has cooled, but the longer-term thesis remains intact. At a P/S of 3.9x, the company trades well below Australian biotech peers and a fair level near 7x, suggesting revenue is priced conservatively. A rough fair value via a DCF (discounted cash flow) model puts Telix near A$28.99 per share, implying roughly a 60% discount to today's price. The implied intrinsic value (the stock's true worth from fundamentals) could rise if earnings visibility improves. Risks include BiPASS results and slower Illuccix rollout. Illuccix and Gozellix potential keeps the narrative alive, but near-term clarity is needed.
Go toTop